Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods
American Journal of Epidemiology · 2024
DOI: 10.1093/aje/kwae077 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Epidemiology, 2024. Verfasst von Patricia C Fulkerson und 37 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Allergy and Infectious Diseases, Rockville, MD 20892, United States. Hauptthemen laut MEDLINE: COVID-19, Family Characteristics, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
The Human Epidemiology and Response to SARS-CoV-2 (HEROS) Study is a prospective, multicity, 6-month incidence study conducted from May 2020 to February 2021. The objectives were to identify risk factors for SARS-CoV-2 infection and household transmission among children and people with asthma and allergic diseases, and to use the host nasal transcriptome sampled longitudinally to understand infection risk and sequelae at the molecular level. To overcome challenges of clinical study implementation due to the coronavirus pandemic, this surveillance study used direct-to-participant methods to remotely enroll and prospectively follow eligible children who are participants in other National Institutes of Health–funded pediatric research studies and their household members. Households participated in weekly surveys and biweekly nasal sampling regardless of symptoms. The aim of this report is to widely share the methods and study instruments and to describe the rationale, design, execution, logistics, and characteristics of a large, observational, household-based, remote cohort study of SARS-CoV-2 infection and transmission in households with children. The study enrolled a total of 5598 individuals, including 1913 principal participants (children), 1913 primary caregivers, 729 secondary caregivers, and 1043 other household children. This study was successfully implemented without necessitating any in-person research visits and provides an approach for rapid execution of clinical research. Trial registration: ClinicalTrials.gov. Identifier: NCT04375761
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute of Allergy and Infectious Diseases, Rockville, MD 20892, United States.
- Rho, Inc., Chapel Hill, NC 27713, United States.
- Marshfield Clinic Research Institute, Marshfield Clinic Health System, Marshfield, WI 54449, United States.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
- Vanderbilt Coordinating Center, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
- Department of Medicine, Center for Asthma Research, Vanderbilt University Medical Center, Nashville, TN 37232, United States.
ORCID-Profile: Tina V Hartert
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NIH HHS
- Henry Ford Health System
- Vanderbilt University
- Columbia University Medical Center
- Rho
- NIEHS NIH HHS
Zitieren
APA
Fulkerson, P. C., Lussier, S. J., Bendixsen, C. G., Castina, S. M., Gebretsadik, T., Marlin, J. S., Russell, P. B., Seibold, M. A., Everman, J. L., Moore, C. M., Snyder, B. M., Thompson, K., Tregoning, G. S., Wellford, S., Arbes, S. J., Bacharier, L. B., Calatroni, A., Camargo, C. A., Dupont, W. D., …, & Heros Study Team, O. B. O. T. (2024). Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwae077
Vancouver
Fulkerson PC, Lussier SJ, Bendixsen CG, Castina SM, Gebretsadik T, Marlin JS, et al. Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods. American Journal of Epidemiology. 2024. doi:10.1093/aje/kwae077
BibTeX
@article{Fulkerson2024,
author = {Fulkerson, Patricia C and Lussier, Stephanie J and Bendixsen, Casper G and Castina, Sharon M and Gebretsadik, Tebeb and Marlin, Jessica S and Russell, Patty B and Seibold, Max A and Everman, Jamie L and Moore, Camille M and Snyder, Brittney M and Thompson, Kathy and Tregoning, George S and Wellford, Stephanie and Arbes, Samuel J and Bacharier, Leonard B and Calatroni, Agustin and Camargo, Carlos A and Dupont, William D and Furuta, Glenn T and Gruchalla, Rebecca S and Gupta, Ruchi S and Hershey, Gurjit Khurana and Jackson, Daniel J and Johnson, Christine C and Kattan, Meyer and Liu, Andrew H and Murrison, Liza and O'Connor, George T and Phipatanakul, Wanda and Rivera-Spoljaric, Katherine and Rothenberg, Marc E and Seroogy, Christine M and Teach, Stephen J and Zoratti, Edward M and Togias, Alkis and Hartert, Tina V and Heros Study Team, On Behalf Of The},
title = {Human Epidemiology and Response to SARS-CoV-2 (HEROS): objectives, design, and enrollment results of a 12-city remote observational surveillance study of households with children, using direct-to-participant methods},
journal = {American Journal of Epidemiology},
year = {2024},
doi = {10.1093/aje/kwae077}
}
EUVIMED